scholarly journals Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis

2020 ◽  
Author(s):  
Emily L. Ryon ◽  
Joshua P. Kronenfeld ◽  
Rachel M. Lee ◽  
Adam Yopp ◽  
Annie Wang ◽  
...  
Keyword(s):  
United States ◽  
Hepatocellular Carcinoma ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Surgical Management ◽  
Safety Net ◽  
The United States ◽  
Vein Thrombosis ◽  
Academic Center ◽  
Collaborative Analysis

The Role of Interventional Radiology in the Pretransplant Management of Hepatocellular Carcinoma and Portal Vein Thrombosis

2019 ◽  
Vol 03 (04) ◽  
pp. 263-269
Author(s):  
Karen Shmelev ◽  
Bartley Thornburg
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Interventional Radiology ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
The United States ◽  
Primary Liver Tumor ◽  
Vein Thrombosis ◽  
Portal Veins

AbstractHepatocellular carcinoma (HCC) is the most common primary liver tumor and is currently the leading indication for liver transplantation in the United States. Liver transplantation may provide a curative option for patients with HCC, but some present outside of the transplant criteria. Additionally, as the criteria for liver transplant eligibility in HCC are expanded and the incidence of disease increases, waitlist times are becoming progressively longer, which increases the chance of a patient suffering from disease progression while awaiting an organ becoming ineligible for transplant. Multiple studies have demonstrated the successful use of locoregional therapies, including trans-arterial chemoembolization and trans-arterial radioembolization, in downstaging HCC to within transplant criteria, as well as in preventing progression of disease in patients already listed for transplant. Cirrhotic patients also commonly develop portal vein thrombosis (PVT), which is a contraindication to transplantation at many centers. PVT can lead to worsened outcomes after transplant depending on the type of portal venous reconstruction that is performed. The purpose of this article is to discuss the integral role of interventional radiology in the care of these patients, including the role of transarterial therapies in the pretransplant treatment of HCC and the use of endovascular techniques to recanalize thrombosed portal veins in order to establish or maintain transplant eligibility.

scholarly journals Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States

2011 ◽  
Vol 17 (9) ◽  
pp. 1066-1072 ◽  
Author(s):  
Seth A. Waits ◽  
Brandon M. Wojcik ◽  
Shijie Cai ◽  
Amit K. Mathur ◽  
Michael J. Englesbe
Keyword(s):  
United States ◽  
Portal Vein ◽  
Liver Transplant ◽  
Portal Vein Thrombosis ◽  
The United States ◽  
Vein Thrombosis ◽  
Pediatric Liver ◽  
Transplant Candidates ◽  
Pediatric Liver Transplant

scholarly journals Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Thrombosis: A Perspective on Survival

2014 ◽  
Vol 29 (6) ◽  
pp. 430-436 ◽  
Author(s):  
Yadav Ajit ◽  
Hariprasad Sudarsan ◽  
Gupta Saumya ◽  
Agarwal Abhishek ◽  
Redhu Navneet ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Transarterial Chemoembolization ◽  
Vein Thrombosis ◽  
Unresectable Hepatocellular Carcinoma

The Presence of Portal Vein Thrombosis Alters the Classic Enhancement Associated with Diagnosis of Hepatocellular Carcinoma

2015 ◽  
Vol 60 (7) ◽  
pp. 2196-2200 ◽  
Author(s):  
Nadia K. Umar ◽  
Maaz B. Badshah ◽  
Kumar Sandrasegaran ◽  
Marwan Ghabril ◽  
Saurabh Agarwal ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Vein Thrombosis
Sign in / Sign up

Export Citation Format

Share Document